We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Mixed Earnings Results for Amgen, TakeTwo; Chegg Jumps on Beat
Read MoreHide Full Article
All four major market indexes have now posted two negative trading days in the last three, with the Dow barely eking out gains of +0.004% today and staving off a third day trading lower in a row. The S&P 500 was flat a half hour ahead of the closing bell, but dipped -0.37% by the end. Similarly, the Nasdaq fell further into the red in the last half hour of trading, -0.58% on the day. The small-cap Russell 2000 gained +0.51% in regular trading.
By sector, we’re seeing much the same picture we have for a while: Energy leads all industries again, on strong demand and higher prices; the laggards were again Communication Services and Tech. Meanwhile, Treasury yields continue to tick up over time: the 10-year is now +1.914% and the 2-year is +1.294%. The Nasdaq is not -14% off its record highs last November, while the S&P is -7% from its all-time highs reached early January.
After Monday’s close, more companies reported earnings results, including Amgen (AMGN - Free Report) , which posted a mixed Q4: earnings of $4.36 per share outpacing the $4.14 in the Zacks consensus, while revenues of $6.85 billion missed the expected $6.91 billion in the quarter. It’s the third-straight earnings beat for the biotech major, and as sales for osteoporosis drug Prolia grew +17% in the quarter, other treatments in the company’s portfolio underperformed expectations. Shares were up initially in late trading, but are now exactly flat.
TakeTwo Interactive (TTWO - Free Report) shares tumbled -5% before regaining some buoyancy in its fiscal Q3, as the Grand Theft Auto and NBA 2K maker beat on earnings — $1.24 per share versus $1.13 expected — but missed on sales: $866 million versus $872 million in the Zacks consensus. Q4 bookings guidance disappointed, coming down to 808-858 million from 924 million expected by analysts. TakeTwo has posted only one earnings miss in the past five years.
Silicon Valley-based education technology firm Chegg (CHGG - Free Report) is up a nice +15% after hours on its Q4 beat-and-raise Monday afternoon. Earnings of 38 cents per share on $207 million in sales outperformed the 31 cents per share and $195 million analysts were looking for. A 20% surge in services revenues helped Q1 revenues guidance to $200-205 million from $198 million in the Zacks consensus. Shares are back to roughly where they were prior to a big fall in share price back in early November.
Tomorrow we look forward to earnings reports from big companies like Pfizer (PFE - Free Report) and BP (BP - Free Report) , along with many others. On the economic report side, look for an NHIB Small Business survey for January and International Trade numbers from December, and Real Household Debt for Q4.
Image: Bigstock
Mixed Earnings Results for Amgen, TakeTwo; Chegg Jumps on Beat
All four major market indexes have now posted two negative trading days in the last three, with the Dow barely eking out gains of +0.004% today and staving off a third day trading lower in a row. The S&P 500 was flat a half hour ahead of the closing bell, but dipped -0.37% by the end. Similarly, the Nasdaq fell further into the red in the last half hour of trading, -0.58% on the day. The small-cap Russell 2000 gained +0.51% in regular trading.
By sector, we’re seeing much the same picture we have for a while: Energy leads all industries again, on strong demand and higher prices; the laggards were again Communication Services and Tech. Meanwhile, Treasury yields continue to tick up over time: the 10-year is now +1.914% and the 2-year is +1.294%. The Nasdaq is not -14% off its record highs last November, while the S&P is -7% from its all-time highs reached early January.
After Monday’s close, more companies reported earnings results, including Amgen (AMGN - Free Report) , which posted a mixed Q4: earnings of $4.36 per share outpacing the $4.14 in the Zacks consensus, while revenues of $6.85 billion missed the expected $6.91 billion in the quarter. It’s the third-straight earnings beat for the biotech major, and as sales for osteoporosis drug Prolia grew +17% in the quarter, other treatments in the company’s portfolio underperformed expectations. Shares were up initially in late trading, but are now exactly flat.
TakeTwo Interactive (TTWO - Free Report) shares tumbled -5% before regaining some buoyancy in its fiscal Q3, as the Grand Theft Auto and NBA 2K maker beat on earnings — $1.24 per share versus $1.13 expected — but missed on sales: $866 million versus $872 million in the Zacks consensus. Q4 bookings guidance disappointed, coming down to 808-858 million from 924 million expected by analysts. TakeTwo has posted only one earnings miss in the past five years.
Silicon Valley-based education technology firm Chegg (CHGG - Free Report) is up a nice +15% after hours on its Q4 beat-and-raise Monday afternoon. Earnings of 38 cents per share on $207 million in sales outperformed the 31 cents per share and $195 million analysts were looking for. A 20% surge in services revenues helped Q1 revenues guidance to $200-205 million from $198 million in the Zacks consensus. Shares are back to roughly where they were prior to a big fall in share price back in early November.
Tomorrow we look forward to earnings reports from big companies like Pfizer (PFE - Free Report) and BP (BP - Free Report) , along with many others. On the economic report side, look for an NHIB Small Business survey for January and International Trade numbers from December, and Real Household Debt for Q4.
Questions or comments about this article and/or its author? Click here>>